Cortés-Camacho, F.; Zambrano-Vásquez, O.R.; Aréchaga-Ocampo, E.; Castañeda-Sánchez, J.I.; Gonzaga-Sánchez, J.G.; Sánchez-Gloria, J.L.; Sánchez-Lozada, L.G.; Osorio-Alonso, H.
Sodium–Glucose Cotransporter Inhibitors: Cellular Mechanisms Involved in the Lipid Metabolism and the Treatment of Chronic Kidney Disease Associated with Metabolic Syndrome. Antioxidants 2024, 13, 768.
https://doi.org/10.3390/antiox13070768
AMA Style
Cortés-Camacho F, Zambrano-Vásquez OR, Aréchaga-Ocampo E, Castañeda-Sánchez JI, Gonzaga-Sánchez JG, Sánchez-Gloria JL, Sánchez-Lozada LG, Osorio-Alonso H.
Sodium–Glucose Cotransporter Inhibitors: Cellular Mechanisms Involved in the Lipid Metabolism and the Treatment of Chronic Kidney Disease Associated with Metabolic Syndrome. Antioxidants. 2024; 13(7):768.
https://doi.org/10.3390/antiox13070768
Chicago/Turabian Style
Cortés-Camacho, Fernando, Oscar René Zambrano-Vásquez, Elena Aréchaga-Ocampo, Jorge Ismael Castañeda-Sánchez, José Guillermo Gonzaga-Sánchez, José Luis Sánchez-Gloria, Laura Gabriela Sánchez-Lozada, and Horacio Osorio-Alonso.
2024. "Sodium–Glucose Cotransporter Inhibitors: Cellular Mechanisms Involved in the Lipid Metabolism and the Treatment of Chronic Kidney Disease Associated with Metabolic Syndrome" Antioxidants 13, no. 7: 768.
https://doi.org/10.3390/antiox13070768
APA Style
Cortés-Camacho, F., Zambrano-Vásquez, O. R., Aréchaga-Ocampo, E., Castañeda-Sánchez, J. I., Gonzaga-Sánchez, J. G., Sánchez-Gloria, J. L., Sánchez-Lozada, L. G., & Osorio-Alonso, H.
(2024). Sodium–Glucose Cotransporter Inhibitors: Cellular Mechanisms Involved in the Lipid Metabolism and the Treatment of Chronic Kidney Disease Associated with Metabolic Syndrome. Antioxidants, 13(7), 768.
https://doi.org/10.3390/antiox13070768
